764 related articles for article (PubMed ID: 20399889)
21. Identification of potential biomarkers of genotoxicity and carcinogenicity in L5178Y mouse lymphoma cells by cDNA microarray analysis.
Kim JY; Kwon J; Kim JE; Koh WS; Chung MK; Yoon S; Song CW; Lee M
Environ Mol Mutagen; 2005; 45(1):80-9. PubMed ID: 15612046
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of the utility of the lifetime mouse bioassay in the identification of cancer hazards for humans.
Osimitz TG; Droege W; Boobis AR; Lake BG
Food Chem Toxicol; 2013 Oct; 60():550-62. PubMed ID: 23954551
[TBL] [Abstract][Full Text] [Related]
23. In vivo Comet assay on isolated kidney cells to distinguish genotoxic carcinogens from epigenetic carcinogens or cytotoxic compounds.
Nesslany F; Zennouche N; Simar-Meintières S; Talahari I; Nkili-Mboui EN; Marzin D
Mutat Res; 2007 Jun; 630(1-2):28-41. PubMed ID: 17507283
[TBL] [Abstract][Full Text] [Related]
24. A comparison of transcriptomic and metabonomic technologies for identifying biomarkers predictive of two-year rodent cancer bioassays.
Thomas RS; O'Connell TM; Pluta L; Wolfinger RD; Yang L; Page TJ
Toxicol Sci; 2007 Mar; 96(1):40-6. PubMed ID: 17114358
[TBL] [Abstract][Full Text] [Related]
25. Genomic models of short-term exposure accurately predict long-term chemical carcinogenicity and identify putative mechanisms of action.
Gusenleitner D; Auerbach SS; Melia T; Gómez HF; Sherr DH; Monti S
PLoS One; 2014; 9(7):e102579. PubMed ID: 25058030
[TBL] [Abstract][Full Text] [Related]
26. Application of genomic biomarkers to predict increased lung tumor incidence in 2-year rodent cancer bioassays.
Thomas RS; Pluta L; Yang L; Halsey TA
Toxicol Sci; 2007 May; 97(1):55-64. PubMed ID: 17311802
[TBL] [Abstract][Full Text] [Related]
27. The comet assay with multiple mouse organs: comparison of comet assay results and carcinogenicity with 208 chemicals selected from the IARC monographs and U.S. NTP Carcinogenicity Database.
Sasaki YF; Sekihashi K; Izumiyama F; Nishidate E; Saga A; Ishida K; Tsuda S
Crit Rev Toxicol; 2000 Nov; 30(6):629-799. PubMed ID: 11145306
[TBL] [Abstract][Full Text] [Related]
28. Issues in the design and interpretation of chronic toxicity and carcinogenicity studies in rodents: approaches to dose selection.
Rhomberg LR; Baetcke K; Blancato J; Bus J; Cohen S; Conolly R; Dixit R; Doe J; Ekelman K; Fenner-Crisp P; Harvey P; Hattis D; Jacobs A; Jacobson-Kram D; Lewandowski T; Liteplo R; Pelkonen O; Rice J; Somers D; Turturro A; West W; Olin S
Crit Rev Toxicol; 2007; 37(9):729-837. PubMed ID: 17957539
[TBL] [Abstract][Full Text] [Related]
29. Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective.
Bolt HM; Foth H; Hengstler JG; Degen GH
Toxicol Lett; 2004 Jun; 151(1):29-41. PubMed ID: 15177638
[TBL] [Abstract][Full Text] [Related]
30. Gene ontology mapping as an unbiased method for identifying molecular pathways and processes affected by toxicant exposure: application to acute effects caused by the rodent non-genotoxic carcinogen diethylhexylphthalate.
Currie RA; Bombail V; Oliver JD; Moore DJ; Lim FL; Gwilliam V; Kimber I; Chipman K; Moggs JG; Orphanides G
Toxicol Sci; 2005 Aug; 86(2):453-69. PubMed ID: 15901911
[TBL] [Abstract][Full Text] [Related]
31. Prediction of rodent carcinogenic potential of naturally occurring chemicals in the human diet using high-throughput QSAR predictive modeling.
Valerio LG; Arvidson KB; Chanderbhan RF; Contrera JF
Toxicol Appl Pharmacol; 2007 Jul; 222(1):1-16. PubMed ID: 17482223
[TBL] [Abstract][Full Text] [Related]
32. Differential display in rat livers treated for 13 weeks with phenobarbital implicates a role for metabolic and oxidative stress in nongenotoxic carcinogenicity.
Elrick MM; Kramer JA; Alden CL; Blomme EA; Bunch RT; Cabonce MA; Curtiss SW; Kier LD; Kolaja KL; Rodi CP; Morris DL
Toxicol Pathol; 2005; 33(1):118-26. PubMed ID: 15805063
[TBL] [Abstract][Full Text] [Related]
33. How useful are chronic (life-span) toxicology studies in rodents in identifying pharmaceuticals that pose a carcinogenic risk to humans?
Monro A
Adverse Drug React Toxicol Rev; 1993; 12(1):5-34. PubMed ID: 8513076
[TBL] [Abstract][Full Text] [Related]
34. Comparison of hepatocarcinogen-induced gene expression profiles in conventional primary rat hepatocytes with in vivo rat liver.
Doktorova TY; Ellinger-Ziegelbauer H; Vinken M; Vanhaecke T; van Delft J; Kleinjans J; Ahr HJ; Rogiers V
Arch Toxicol; 2012 Sep; 86(9):1399-411. PubMed ID: 22484513
[TBL] [Abstract][Full Text] [Related]
35. Short-term tests for defining mutagenic carcinogens.
Waters MD; Stack HF; Jackson MA
IARC Sci Publ; 1999; (146):499-536. PubMed ID: 10353401
[TBL] [Abstract][Full Text] [Related]
36. Current and future use of genomics data in toxicology: opportunities and challenges for regulatory applications.
Goetz AK; Singh BP; Battalora M; Breier JM; Bailey JP; Chukwudebe AC; Janus ER
Regul Toxicol Pharmacol; 2011 Nov; 61(2):141-53. PubMed ID: 21840362
[TBL] [Abstract][Full Text] [Related]
37. Characteristic expression profiles induced by genotoxic carcinogens in rat liver.
Ellinger-Ziegelbauer H; Stuart B; Wahle B; Bomann W; Ahr HJ
Toxicol Sci; 2004 Jan; 77(1):19-34. PubMed ID: 14600272
[TBL] [Abstract][Full Text] [Related]
38. Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification.
Jennen DG; Magkoufopoulou C; Ketelslegers HB; van Herwijnen MH; Kleinjans JC; van Delft JH
Toxicol Sci; 2010 May; 115(1):66-79. PubMed ID: 20106945
[TBL] [Abstract][Full Text] [Related]
39. Epidemiological and experimental applications to occupational cancer prevention.
Vainio H; Hemminki K
J UOEH; 1989 Mar; 11 Suppl():323-45. PubMed ID: 2664947
[TBL] [Abstract][Full Text] [Related]
40. Formaldehyde and glutaraldehyde and nasal cytotoxicity: case study within the context of the 2006 IPCS Human Framework for the Analysis of a cancer mode of action for humans.
McGregor D; Bolt H; Cogliano V; Richter-Reichhelm HB
Crit Rev Toxicol; 2006; 36(10):821-35. PubMed ID: 17118731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
